Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1025 of 3546 entries
View as:

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00148941 Org: User:
Start: 01/06/05 End: 12/04/06 Due: 12/04/07

Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00244751 Org: User:
Start: 11/02/05 End: 03/13/08 Due: 03/13/09

Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT01648101 Org: User:
Start: 08/29/12 End: 12/23/13 Due: 12/23/14

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00783003 Org: User:
Start: 11/10/08 End: 02/06/09 Due: 02/06/10

GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia

Phase: N/A Priority: Normal
NCT ID: NCT01345253 Org: User:
Start: 05/23/11 End: 09/21/18 Due: 09/21/19

A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01476137 Org: User:
Start: 10/26/11 End: 03/12/13 Due: 03/12/14

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01767376 Org: User:
Start: 01/10/13 End: 01/16/14 Due: 01/16/15

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Phase: N/A Priority: Normal
NCT ID: NCT00383383 Org: User:
Start: 12/31/99 End: - Due: -

A Study Assessing GW870086's Potential to Cause Skin Thinning

Phase: N/A Priority: Normal
NCT ID: NCT01381445 Org: User:
Start: 04/14/11 End: 07/07/11 Due: 07/07/12

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Phase: N/A Priority: Normal
NCT ID: NCT02082639 Org: User:
Start: 02/28/15 End: 11/30/15 Due: 11/30/16

A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques

Phase: N/A Priority: Normal
NCT ID: NCT02350426 Org: User:
Start: 08/12/15 End: 10/26/16 Due: 10/26/17

Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Phase: N/A Priority: Normal
NCT ID: NCT01453998 Org: User:
Start: 10/14/11 End: 11/12/12 Due: 11/12/13

WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01763463 Org: User:
Start: 07/31/12 End: 05/31/13 Due: 05/31/14

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

Phase: N/A Priority: Normal
NCT ID: NCT00289744 Org: User:
Start: 02/16/04 End: 04/15/09 Due: 04/15/10

Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days

Phase: N/A Priority: Normal
NCT ID: NCT00989404 Org: User:
Start: 10/12/09 End: 12/07/09 Due: 12/07/10

A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00823940 Org: User:
Start: 01/13/09 End: 04/27/09 Due: 04/27/10

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Phase: N/A Priority: Normal
NCT ID: NCT00328965 Org: User:
Start: 11/30/04 End: 05/31/06 Due: 05/31/07

A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02289482 Org: User:
Start: 11/17/14 End: 03/10/15 Due: 03/10/16

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action

Phase: N/A Priority: Normal
NCT ID: NCT00118729 Org: User:
Start: 04/30/05 End: 08/31/05 Due: 08/31/06

Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)

Phase: N/A Priority: Normal
NCT ID: NCT00240539 Org: User:
Start: 10/31/03 End: 07/31/08 Due: 07/31/09

A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts

Phase: N/A Priority: Normal
NCT ID: NCT02899377 Org: User:
Start: 11/18/16 End: 07/12/18 Due: 07/12/19

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT01231607 Org: User:
Start: 10/28/10 End: 02/28/12 Due: 02/28/13

Special Drug Use Investigation for PAXIL Tablet (Long-term)

Phase: N/A Priority: Normal
NCT ID: NCT01371448 Org: User:
Start: 05/31/01 End: 09/30/05 Due: 09/30/06

A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough

Phase: N/A Priority: Normal
NCT ID: NCT03372603 Org: User:
Start: 04/05/18 End: 10/08/18 Due: 10/08/19

Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam

Phase: N/A Priority: Normal
NCT ID: NCT01153841 Org: User:
Start: 02/17/11 End: 07/26/11 Due: 07/26/12